Medicus Pharma (CVE:MDC – Get Free Report) was upgraded by D Boral Capital to a “strong-buy” rating in a report issued on Monday,Zacks.com reports.
Medicus Pharma Stock Performance
Recommended Stories
- Five stocks we like better than Medicus Pharma
- What Are the U.K. Market Holidays? How to Invest and Trade
- Beware of BigBear.ai: Insiders Are Selling—Should You?
- Compound Interest and Why It Matters When Investing
- CrowdStrike Stock is a Buy as Cyberthreat Environment Expands
- How to Choose Top Rated Stocks
- Congress! Who Traded What During the Tariff-Induced Meltdown
Receive News & Ratings for Medicus Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicus Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
